TrialAnnals of the American Thoracic Society2026

Rodatristat ethyl decreases activity in pulmonary arterial hypertension: results from the ELEVATE-2 trial.

Daniel J Lachant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.